(Q30843470)

27 June 2017

Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of Hepatitis C virus (English)

1 reference

27 June 2017

1 reference

Anton Poliakov

1

1 reference

27 June 2017

Ina Hubatsch

2

1 reference

27 June 2017

Cynthia F Shuman

3

1 reference

27 June 2017

Gun Stenberg

4

1 reference

27 June 2017

U Helena Danielson

5

1 reference

27 June 2017

1 August 2002

1 reference

Protein Expression and Purification

27 June 2017

1 reference

27 June 2017

25

1 reference

27 June 2017

3

1 reference

27 June 2017

363-371

1 reference

Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Mutational analysis of the hepatitis C virus RNA helicase

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Novel approaches to the treatment of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

A 'C' change for hepatitis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Optimization of the P'-region of peptide inhibitors of hepatitis C virus NS3/4A protease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

A novel recombinant single-chain hepatitis C virus ns3-ns4a protein with improved helicase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

A novel high throughput screening assay for HCV NS3 helicase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Enzymatic properties of hepatitis C virus NS3-associated helicase

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Specific Interaction of Hepatitis C Virus Protease/Helicase NS3 with the 3'-Terminal Sequences of Viral Positive- and Negative-Strand RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

A high-throughput radiometric assay for hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2802%2900042-6

7 January 2021

10.1016/S1046-5928(02)00042-6

Identifiers

DOI

1 reference

release_6khfuxzlejehdit2a7ycwle7ca

27 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6khfuxzlejehdit2a7ycwle7ca

24 November 2022

mapped directly with Wikidata item

1 reference